Brugada Panel
New York
Approved
Genes
Conditions
- Brugada Syndrome
Clinical Utility
- Confirmation of a clinical diagnosis in symptomatic patients
- Risk assessment of asymptomatic family members of a proband with Brugada syndrome
- Recurrence risk calculation
- Differentiation of hereditary BrS from other acquired or genetic heart conditions
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Test Code
481
CPT Codes*
81404x1, 81406x2, 81407x1, 81479x3
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
For Providers
Targeted Variant Testing